Skip to content
The new realism in venture capital is healthy

The new realism in venture capital is healthy

Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class

Read More

​ Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class  Moneycontrol Latest News Read More  

Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class

The new realism in venture capital is healthy

The new realism in venture capital is healthy

Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class

Read More

​ Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class  Moneycontrol Latest News Read More  

Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class

The new realism in venture capital is healthy

The new realism in venture capital is healthy

Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class

Read More

​ Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class  Moneycontrol Latest News Read More  

Rising stockpile of ‘dry powder’ is a sign of private capital’s growing attraction as an asset class

Foreign direct investment to China slumps to 30 year low

Foreign direct investment to China slumps to 30 year low

China’s direct investment liabilities in its balance of payments stood at $33 billion last year, according to data from the State Administration of Foreign Exchange released Sunday.

Read More

​ China’s direct investment liabilities in its balance of payments stood at $33 billion last year, according to data from the State Administration of Foreign Exchange released Sunday. China’s direct investment liabilities in its balance of payments stood at $33 billion last year, according to data from the State Administration of Foreign Exchange released Sunday.  Moneycontrol Latest News Read More  

China’s direct investment liabilities in its balance of payments stood at $33 billion last year, according to data from the State Administration of Foreign Exchange released Sunday.

Neutral Muthoot Finance; target of Rs 1440: Motilal Oswal

Neutral Muthoot Finance; target of Rs 1440: Motilal Oswal

Motilal Oswal recommended Neutral rating on Muthoot Finance with a target price of Rs 1440 in its research report dated January 14, 2024.

Read More

​ Motilal Oswal recommended Neutral rating on Muthoot Finance with a target price of Rs 1440 in its research report dated January 14, 2024. Motilal Oswal recommended Neutral rating on Muthoot Finance with a target price of Rs 1440 in its research report dated January 14, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Muthoot Finance with a target price of Rs 1440 in its research report dated January 14, 2024.

Neutral Ipca Laboratories; target of Rs 1080: Motilal Oswal

Neutral Ipca Laboratories; target of Rs 1080: Motilal Oswal

Motilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated January 15, 2024.

Read More

​ Motilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated January 15, 2024. Motilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated January 15, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated January 15, 2024.

Neutral Deepak Nitrite; target of Rs 2185: Motilal Oswal

Neutral Deepak Nitrite; target of Rs 2185: Motilal Oswal

Motilal Oswal recommended Neutral rating on Deepak Nitrite with a target price of Rs 2185 in its research report dated January 15, 2024.

Read More

​ Motilal Oswal recommended Neutral rating on Deepak Nitrite with a target price of Rs 2185 in its research report dated January 15, 2024. Motilal Oswal recommended Neutral rating on Deepak Nitrite with a target price of Rs 2185 in its research report dated January 15, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Deepak Nitrite with a target price of Rs 2185 in its research report dated January 15, 2024.

Neutral Aditya Birla Fashion and Retail; target of Rs 260: Motilal Oswal

Neutral Aditya Birla Fashion and Retail; target of Rs 260: Motilal Oswal

Motilal Oswal recommended Neutral rating on Aditya Birla Fashion and Retail with a target price of Rs 260 in its research report dated January 15, 2024.

Read More

​ Motilal Oswal recommended Neutral rating on Aditya Birla Fashion and Retail with a target price of Rs 260 in its research report dated January 15, 2024. Motilal Oswal recommended Neutral rating on Aditya Birla Fashion and Retail with a target price of Rs 260 in its research report dated January 15, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Aditya Birla Fashion and Retail with a target price of Rs 260 in its research report dated January 15, 2024.

Healthcare Global at 52-week high on buzz over PE funds jostling for controlling stake

Healthcare Global at 52-week high on buzz over PE funds jostling for controlling stake

The three private equity firms are eyeing the 60.41 percent controlling stake in the cancer hospital chain, currently held by CVC Capital.

Read More

​ The three private equity firms are eyeing the 60.41 percent controlling stake in the cancer hospital chain, currently held by CVC Capital. The three private equity firms are eyeing the 60.41 percent controlling stake in the cancer hospital chain, currently held by CVC Capital.  Moneycontrol Latest News Read More  

The three private equity firms are eyeing the 60.41 percent controlling stake in the cancer hospital chain, currently held by CVC Capital.

RVNL zooms 12% on Rs 65,000-crore order book, offshore growth plans

RVNL zooms 12% on Rs 65,000-crore order book, offshore growth plans

Rail Vikas Nigam Ltd (RVNL), under the Ministry of Railways, ​is involved in the project development, financing and implementation of projects related to rail infrastructure.

Read More

​ Rail Vikas Nigam Ltd (RVNL), under the Ministry of Railways, ​is involved in the project development, financing and implementation of projects related to rail infrastructure. Rail Vikas Nigam Ltd (RVNL), under the Ministry of Railways, ​is involved in the project development, financing and implementation of projects related to rail infrastructure.  Moneycontrol Latest News Read More  

Rail Vikas Nigam Ltd (RVNL), under the Ministry of Railways, ​is involved in the project development, financing and implementation of projects related to rail infrastructure.

en_USEnglish